Live Oak Health Sciences Fund
$27.49+$0.41 (+1.51%)
Live Oak Health Sciences Fund’s quoted price sits in the upper half of its reported 52-week range, 0.04% below the high.
NASDAQ · MYIFX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 12:07 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Monetta Young Investor Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 10.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Monetta Young Investor Growth Fund’s forward annual dividend is $3.56 per share, paid annual. The forward yield is 17.55% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The fund invests approximately 50% of its assets in exchange-traded funds ("ETFs") that seek to track the S&P 500® Index or other broad-based market indices that primarily include stocks of large capitalization U.S. companies. The balance of the fund is directly invested in common stocks of companies of all market capitalization ranges and is diversified among industries and market sectors.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:16 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$27.49+$0.41 (+1.51%)
Live Oak Health Sciences Fund’s quoted price sits in the upper half of its reported 52-week range, 0.04% below the high.
$13.41-$0.12 (-0.89%)
WesMark Tactical Opportunity Fund’s quoted price sits in the upper half of its reported 52-week range, 3.8% below the high.
$39.89-$0.18 (-0.45%)
Nuveen Large Cap Select Fund Class C’s quoted price sits in the upper half of its reported 52-week range, 4.46% below the high.
$12.16+$0.01 (+0.08%)
T. Rowe Price Target Retirement 2005 Fund’s quoted price sits in the upper half of its reported 52-week range, 1.46% below the high.
$24.78+$0.27 (+1.1%)
Monongahela All Cap Value Fund’s quoted price sits in the upper half of its reported 52-week range, 2.17% below the high.
$53.47-$0.01 (-0.02%)
AMG GW&K International Small Cap Fund’s quoted price sits in the upper half of its reported 52-week range, 1.94% below the high.
$55.10-$2.29 (-3.99%)
Paradigm Value Fund’s quoted price sits in the lower half of its reported 52-week range, 13.7% below the high.
$34.26-$0.18 (-0.52%)
Sphere 500 Climate Fund’s quoted price sits in the upper half of its reported 52-week range, 2.14% below the high.